Principal Financial Group Inc. cut its holdings in shares of Monsanto Company (NYSE:MON) by 1.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 644,541 shares of the company’s stock after selling 6,207 shares during the quarter. Principal Financial Group Inc. owned about 0.15% of Monsanto worth $77,229,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of MON. Thrivent Financial For Lutherans lifted its holdings in shares of Monsanto by 5.3% during the first quarter. Thrivent Financial For Lutherans now owns 16,257 shares of the company’s stock worth $1,839,000 after buying an additional 820 shares during the last quarter. Loomis Sayles & Co. L P lifted its holdings in shares of Monsanto by 241.1% during the first quarter. Loomis Sayles & Co. L P now owns 102,338 shares of the company’s stock worth $11,585,000 after buying an additional 72,338 shares during the last quarter. Global X Management Co. LLC lifted its holdings in shares of Monsanto by 20.8% during the first quarter. Global X Management Co. LLC now owns 3,584 shares of the company’s stock worth $406,000 after buying an additional 617 shares during the last quarter. MARSHALL WACE ASIA Ltd acquired a new position in shares of Monsanto during the first quarter worth approximately $63,977,000. Finally, Guardian Life Insurance Co. of America lifted its holdings in shares of Monsanto by 0.7% during the first quarter. Guardian Life Insurance Co. of America now owns 1,689 shares of the company’s stock worth $191,000 after buying an additional 11 shares during the last quarter. Institutional investors own 74.50% of the company’s stock.
In other Monsanto news, VP Nicole M. Ringenberg sold 7,890 shares of the business’s stock in a transaction on Monday, October 16th. The stock was sold at an average price of C$122.25, for a total value of C$964,552.50. Following the transaction, the vice president now owns 38,600 shares of the company’s stock, valued at C$4,718,850. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, VP Duraiswami Narain sold 2,860 shares of the business’s stock in a transaction on Monday, September 25th. The stock was sold at an average price of C$120.00, for a total value of C$343,200.00. The disclosure for this sale can be found here. In the last three months, insiders sold 49,236 shares of company stock worth $5,931,934. Insiders own 0.79% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This piece was reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright & trademark law. The legal version of this piece can be viewed at https://www.chaffeybreeze.com/2017/11/13/monsanto-company-mon-shares-sold-by-principal-financial-group-inc.html.
Monsanto Company (MON) opened at C$118.16 on Monday. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.35 and a quick ratio of 0.83. The company has a market capitalization of $52,075.66, a price-to-earnings ratio of 21.39, a price-to-earnings-growth ratio of 1.70 and a beta of 1.05. Monsanto Company has a one year low of C$97.35 and a one year high of C$122.79.
Monsanto (NYSE:MON) last posted its quarterly earnings data on Wednesday, October 4th. The company reported C$0.20 EPS for the quarter, topping analysts’ consensus estimates of C($0.41) by C$0.61. The company had revenue of C$2.69 billion for the quarter, compared to analyst estimates of C$2.51 billion. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The business’s revenue was up 4.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.07 earnings per share. sell-side analysts expect that Monsanto Company will post 5.74 EPS for the current year.
A number of research firms have recently issued reports on MON. Barclays PLC restated an “equal weight” rating and set a $124.00 price objective (up from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. Royal Bank Of Canada restated a “hold” rating and set a $128.00 price objective on shares of Monsanto in a research report on Wednesday, August 2nd. BMO Capital Markets restated a “buy” rating and set a $128.00 price objective on shares of Monsanto in a research report on Thursday, October 5th. Piper Jaffray Companies set a $128.00 price objective on Monsanto and gave the company a “buy” rating in a research report on Friday, August 11th. Finally, Vetr cut Monsanto from a “buy” rating to a “hold” rating and set a $122.35 price objective on the stock. in a research report on Wednesday, August 2nd. Eleven analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of C$124.61.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.